Assistant Professor of Medicine @CWRUSOM | Transplant Hepatologist @UHhospitals | @MayoClinicGIHep Alumni | @imdartmouth Alumni | Posts are not medical advice
Introducing our final Team presenting at our upcoming #LiverRounds on May 13th!:
Representing @uhhospitals we have Dr. Julie Gartland!
Join us to hear the case of "Lost in Transplantation"!
Register today by visiting https://t.co/9XocxEKfTX
๐#BavenoVIII Best Abstracts Webinar
๐ Tuesday May 5 | 17:00 CET
๐น Body composition & TIPS
๐น LSM in obese MASLD
๐น Early TIPS & ascites (#TEAMTrial)
๐น VCTE in PSVD
๐Free link: https://t.co/LeZHuNkFXT
Meeting ID: 841 4199 8647
Passcode: B8Webinar
#LiverTwitter
The flagella of Helicobacter pylori work like specialised propellers driven by a high-torque rotating motor. These convert chemical energy generated from proton gradients across the bacterial membrane into mechanical rotation. These help the bacteria to navigate the thick mucus of the human stomach to travel from highly acidic areas (pH 2) to areas with a more neutral pH (pH 5.5 to 7.5) where they thrive best.
Using high-resolution electron microscopy imaging, scientists have recently characterised the architecture of this motor which form the building block of flagella, and my god, does this look like a beautiful feat of engineering. ๐ฆ โ๏ธ
Recompensation is reshaping how we understand cirrhosis, but key gaps remain.
Join @salvatore_piano, @elizabeth_verna, and @DrLoomba in two weeks to explore how etiological control enables recompensation, what defines it clinically, and how outcomes may shift for patients. Save your seat: https://t.co/ejuDA5Zt6G
Ashwagandha may not be as safe as previously thought, especially in patients with chronic liver disease.
@AASLDtweets#livertwitter@CWRU_GI@NIH
https://t.co/W8mq6U6bSC
Love this paper
1. Checking ANA in everyone with elevated ALT is unhelpful, sometimes harmful, usually confusing
2. Biopsy when ALT <100 but ANA elevated is not useful
3. Autoimmune hepatitis is a clinical diagnosis and frequently made DESPITE biopsy findings
Are we ready for #ICI use for #HCC AFTER Liver Txp?
https://t.co/dD5hBuyg7O
โ ๏ธ ~50% had progressive HCC
โ ๏ธ 1 pt had a COMPLETE response
โ ๏ธ some had a response but later progressed
โ ๏ธ 20% had rejection, 50% mortality
โ ๏ธ high risk with mTOR and PDL1 expression
Gleaming and proud today as I made a diagnosis of a #HepatitisD superinfection!
Read a great review by @AnnaLok.
https://t.co/cN8iI6YoYs @CWRU_GI
Disheartened to see the only @US_FDA approved treatment in the US is #PEGinterferon.
#Buleviratide is approved in the EU.
Don't wait! Submit your abstract to The Liver Meetingยฎ 2026 and ELEVATE the practice and science of liver disease. Start today >> https://t.co/dsoMD9mf8Y
๐ Deadline: May 28 at 11:59 p.m. EST
๐ Regular Abstract Embargo Lift: October 5
NEW PAPER: Steroids show modest 28-day benefit in severe alcohol-associated hepatitis. @AGA_GIHN talks to corresponding author @juanpabloarab. https://t.co/OFSOlGSLBo #livertwitter#hepatitis
Support looks different for everyone.
For some, itโs a stuffed toy.
For you, it might be a colonoscopy.
Colorectal cancer screening saves lives. Most people at average risk should begin screening at 45 years old. Options include colonoscopy (every 10 years if normal) or stool-based tests done at home at recommended intervals.
The goal? Detect and remove precancerous polyps before they become cancer or catch cancer early, when treatment is most effective.
Protect your peace. Protect your colon. Reach out if you need help getting started ๐
#CRCAwarenessMonth #Punch #Support #EnoughCRC #MayoClinicGI